Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

Drug discovery

May 2008
Promega_DrugDiscovery.jpgIssue 20 of “Cell Notes,” a serial publication of Promega Corp., focuses on drug discovery and screening. The 32-page document includes an article on monitoring viability during gene-directed enzyme prodrug therapy with the CellTiter-Glo assay and human neural progenitor cells, and a discussion on detecting toxicological responses in cells with the bioluminescent GSH-Glo glutathione assay. Other articles address screening traditional Chinese medicines, RNAi knockdown in primary cells, cytochrome P450 activity in rat hepatocytes cultured on a synthetic extracellular matrix, and high-throughput kinase and multiplex cytotoxity assays. Publications that cite the use of Promega reagents and technologies in novel high-throughput screening applications are highlighted.

BiophotonicsBreakthroughMediacellsenzyme prodrug therapyNew MediaPromega Corp.toxicological responses

Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,
x Subscribe to BioPhotonics magazine - FREE!